Sam Ononge
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sam Ononge has a total of 131 co-authors. Here are the top co-authors by number of shared publications:
Katie Lightly
10 shared publicationsAndrew Weeks
9 shared publications- Florence Mirembe
Department of Obstetrics and Gynaecology, Makerere University College of Health Sciences, P.O. Box 7072, Kampala, Uganda
4 shared publications - Andrew Weeks
University of Liverpool
3 shared publications - Josaphat Byamugisha
Department of Obstetrics and Gynaecology, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda
3 shared publications - Noah Kiwanuka
Department of Epidemiology and Biostatistics, School of Public Health, Makerere University, Kampala, Uganda
3 shared publications
Latest Publications
- Open Access
- 14 October 2026
- Published by Elsevier in SSRN Electronic Journal
Factors Associated With Maternal Deaths From Postpartum Haemorrhage In Uganda: A National Surveillance Analysis, 2020–24
Background: Despite postpartum haemorrhage (PPH) being a leading cause of maternal death in sub-Saharan Africa, national data on these fatalities are limited. We examined 5-year maternal mortality trends in Uganda to identify independent factors associated with PPH death.Methods: We analysed all maternal deaths notified to Uganda's national Maternal and Perinatal Death Surveillance and Response system between Jan 1, 2020, and Dec 31, 2024. Causes of death were classified using the WHO ICD-11 MMS framework for maternal mortality. Deaths attributed to PPH were compared with other causes amongst women ≥28 weeks of gestation using multivariable logistic regression model.Findings: Of 5515 maternal deaths, 1362 (24·7%) were attributed to PPH. Amongst women who died after 28 week of gestation, and with complete data (n=3203), PPH death was associated with age ≥35 years (adjusted odds ratio [aOR] 1·30 [95% CI 1·03–1·66]), parity ≥4 (1·30 [1·06–1·59]), previous uterine scar (1·44 [1·24–1·68]), multiple pregnancy (1·85 [1·26–2·73]), anaemia (1·58 [1·30–1·92]), no blood available (2·69 [2·16–3·36]), staffing deficits (1·64 [1·32–2·05]), and delivery at a private facility (2·47 [1·72–3·55]), health centre (1·65 [1·26–2·16]), or home (1·82 [1·38–2·41]) rather than a general hospital.Interpretation: More than 1000 women died each year in Uganda, one in four from PPH. These deaths were associated with modifiable health-system factors as well as known obstetric risk factors. Functional comprehensive emergency obstetric care, a reliable blood supply, adequate skilled and well managed staffing, and targeted antenatal care for women at high risk could reduce PPH deaths.
- 14 October 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessFactors Associated With Maternal Deaths From Postpartum Haemorrhage In Uganda: A National Surveillance Analysis, 2020–24
Background: Despite postpartum haemorrhage (PPH) being a leading cause of maternal death in sub-Saharan Africa, national data on these fatalities are limited. We examined 5-year maternal mortality trends in Uganda to identify independent factors associated with PPH death.Methods: We analysed all maternal deaths notified to Uganda's national Maternal and Perinatal Death Surveillance and Response system between Jan 1, 2020, and Dec 31, 2024. Causes of death were classified using the WHO ICD-11 MMS framework for maternal mortality. Deaths attributed to PPH were compared with other causes amongst women ≥28 weeks of gestation using multivariable logistic regression model.Findings: Of 5515 maternal deaths, 1362 (24·7%) were attributed to PPH. Amongst women who died after 28 week of gestation, and with complete data (n=3203), PPH death was associated with age ≥35 years (adjusted odds ratio [aOR] 1·30 [95% CI 1·03–1·66]), parity ≥4 (1·30 [1·06–1·59]), previous uterine scar (1·44 [1·24–1·68]), multiple pregnancy (1·85 [1·26–2·73]), anaemia (1·58 [1·30–1·92]), no blood available (2·69 [2·16–3·36]), staffing deficits (1·64 [1·32–2·05]), and delivery at a private facility (2·47 [1·72–3·55]), health centre (1·65 [1·26–2·16]), or home (1·82 [1·38–2·41]) rather than a general hospital.Interpretation: More than 1000 women died each year in Uganda, one in four from PPH. These deaths were associated with modifiable health-system factors as well as known obstetric risk factors. Functional comprehensive emergency obstetric care, a reliable blood supply, adequate skilled and well managed staffing, and targeted antenatal care for women at high risk could reduce PPH deaths.
- Open Access
- 22 April 2025
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 5 (4) , e0003562
Cost-effectiveness results comparing heat-stable carbetocin & other uterotonics in postpartum heamorrhage prevention in Uganda
In Uganda, postpartum haemorrhage (PPH) is responsible for 34% of all institutional maternal deaths. Injectable oxytocin is the preferred uterotonic for prevention of PPH. However, in resource-limited settings, the effectiveness of oxytocin is sub-optimal due to efficacy, quality (cold chain storage requirements), and manufacturing standards (poor quality active pharmaceutical ingredients, lack of sterile manufacturing environment, and low-quality manufacturing processes). This study aimed to assess the cost-effectiveness of heat-stable carbetocin, a quality uterotonic newly recommended by WHO and Ugandan Ministry of Health, compared to standard uterotonics for the prevention of PPH in Uganda. A decision tree model was built to assess the cost-effectiveness of heat-stable carbetocin compared to the current standards of care – oxytocin, misoprostol or oxytocoin+misoprostol combination. The model was applied to a hypothetical annual cohort of birthing women eligible for PPH prevention in Uganda’s public health facilities. The evaluation considered direct costs and health outcomes using a public health perspective. The model inputs were obtained through literature review and, whenever referencable information was unavailable or incomplete, from key opinion leaders. Compared to oxytocin, administering heat-stable carbetocin to prevent PPH had a cascading favorable effect and was estimated to avert 57,536 PPH cases, 123 maternal deaths, and 4,203 disability-adjusted life years (DALYs). Heat-stable carbetocin is also cost-saving where the direct cost to the public healthcare system was lower by USD $1,058,353 (UGX 3,998,350,875). The benefits of heat-stable carbetocin were even greater when compared with misoprostol (averted 73,939 PPH events, 273 maternal deaths, and 8,716 DALYs, and lowered public healthcare system costs by USD $2,118,372 [UGX 8,002,996,052]). Heat-stable carbetocin for preventing PPH in Uganda has the potential to reduce PPH events, and subsequently maternal deaths, DALYs, and costs for the public healthcare system. Adopting heat-stable carbetocin will contribute towards achieving the country’s Sustainable Development Goal 3.1.
- 22 April 2025
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 5 (4) , e0003562
Open AccessCost-effectiveness results comparing heat-stable carbetocin & other uterotonics in postpartum heamorrhage prevention in Uganda
In Uganda, postpartum haemorrhage (PPH) is responsible for 34% of all institutional maternal deaths. Injectable oxytocin is the preferred uterotonic for prevention of PPH. However, in resource-limited settings, the effectiveness of oxytocin is sub-optimal due to efficacy, quality (cold chain storage requirements), and manufacturing standards (poor quality active pharmaceutical ingredients, lack of sterile manufacturing environment, and low-quality manufacturing processes). This study aimed to assess the cost-effectiveness of heat-stable carbetocin, a quality uterotonic newly recommended by WHO and Ugandan Ministry of Health, compared to standard uterotonics for the prevention of PPH in Uganda. A decision tree model was built to assess the cost-effectiveness of heat-stable carbetocin compared to the current standards of care – oxytocin, misoprostol or oxytocoin+misoprostol combination. The model was applied to a hypothetical annual cohort of birthing women eligible for PPH prevention in Uganda’s public health facilities. The evaluation considered direct costs and health outcomes using a public health perspective. The model inputs were obtained through literature review and, whenever referencable information was unavailable or incomplete, from key opinion leaders. Compared to oxytocin, administering heat-stable carbetocin to prevent PPH had a cascading favorable effect and was estimated to avert 57,536 PPH cases, 123 maternal deaths, and 4,203 disability-adjusted life years (DALYs). Heat-stable carbetocin is also cost-saving where the direct cost to the public healthcare system was lower by USD $1,058,353 (UGX 3,998,350,875). The benefits of heat-stable carbetocin were even greater when compared with misoprostol (averted 73,939 PPH events, 273 maternal deaths, and 8,716 DALYs, and lowered public healthcare system costs by USD $2,118,372 [UGX 8,002,996,052]). Heat-stable carbetocin for preventing PPH in Uganda has the potential to reduce PPH events, and subsequently maternal deaths, DALYs, and costs for the public healthcare system. Adopting heat-stable carbetocin will contribute towards achieving the country’s Sustainable Development Goal 3.1.
- Open Access
- 12 June 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (6) , e0286361
Randomized trial to compare acceptability of magnesium sulphate administration for preeclampsia and eclampsia: Springfusor pump versus standard of care
Introduction: In low-resource settings, magnesium sulphate (MgSO4) for preeclampsia is administered majorly through an injection into the gluteal muscles 4-hourly for 24 hours. The repeated injections are very painful and may lead to infection, abscess formation, and reduced compliance. Objective: To determine the acceptability of Springfusor® pump for the administration of Magnesium Sulphate in preeclampsia and eclampsia. Design: Randomized Open Label Clinical Trial. Methods: The study was conducted at Kawempe National Referral Hospital. Eligible women had a systolic blood pressure of ≥140mmHg and or diastolic blood pressure >90mmHg, proteinuria ≥+1, and the physician’s decision to start on MgSO4. Four-hundred-ninety-six participants were randomized to a Springfusor® pump group (n = 248) or control (standard of care) (n = 248) administration of MgSO4. Intervention group had a loading dose (4gm of 50% MgSO4 intravenously over 20 minutes) and maintenance therapy (1gm of 50% MgSO4 intravenously per hour for 24 hours) administered using the Springfusor®. The standard of care (SOC) group received a loading dose of 4gm of 20% MgSO4 IV over 15–20 minutes, followed by 10gm of 50% MgSO4 intramuscular (5gm in each buttock) and a maintenance dose of 5gm of 50% MgSO4 was administered IM every 4 hours for 24 hours. Both arms received the rest of the care for preeclampsia/eclampsia as per the hospital guidelines. Acceptability of the method of administration was assessed using a Likert scale (1–5; 1 and 2: acceptable and 3–5: unacceptable). Pain at the site of MgSO4 administration was assessed using a Visual Analogue Scale 1–7, (1 minimal pain and 7 worst pain). Comparisons were assessed with the Chi-square test, Mann Whitney-Wilcoxon test, and Students’ t-test. Results: Intervention arm; was more acceptable than the standard of care arm, (95.3% vs70.3%; p<0.001), had a lower median pain score, (2(CI: 2–2), vs 4(CI: 4–5) p<0.001), and fewer side effects. Maternal mortality was comparable between groups (0.8% in the intervention arm vs 1.2% in the IM arm). Trial registration: Trial No PACTR201712002887266 (https://pactr.samrc.ac.za/).
- 12 June 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (6) , e0286361
Open AccessRandomized trial to compare acceptability of magnesium sulphate administration for preeclampsia and eclampsia: Springfusor pump versus standard of care
Introduction: In low-resource settings, magnesium sulphate (MgSO4) for preeclampsia is administered majorly through an injection into the gluteal muscles 4-hourly for 24 hours. The repeated injections are very painful and may lead to infection, abscess formation, and reduced compliance. Objective: To determine the acceptability of Springfusor® pump for the administration of Magnesium Sulphate in preeclampsia and eclampsia. Design: Randomized Open Label Clinical Trial. Methods: The study was conducted at Kawempe National Referral Hospital. Eligible women had a systolic blood pressure of ≥140mmHg and or diastolic blood pressure >90mmHg, proteinuria ≥+1, and the physician’s decision to start on MgSO4. Four-hundred-ninety-six participants were randomized to a Springfusor® pump group (n = 248) or control (standard of care) (n = 248) administration of MgSO4. Intervention group had a loading dose (4gm of 50% MgSO4 intravenously over 20 minutes) and maintenance therapy (1gm of 50% MgSO4 intravenously per hour for 24 hours) administered using the Springfusor®. The standard of care (SOC) group received a loading dose of 4gm of 20% MgSO4 IV over 15–20 minutes, followed by 10gm of 50% MgSO4 intramuscular (5gm in each buttock) and a maintenance dose of 5gm of 50% MgSO4 was administered IM every 4 hours for 24 hours. Both arms received the rest of the care for preeclampsia/eclampsia as per the hospital guidelines. Acceptability of the method of administration was assessed using a Likert scale (1–5; 1 and 2: acceptable and 3–5: unacceptable). Pain at the site of MgSO4 administration was assessed using a Visual Analogue Scale 1–7, (1 minimal pain and 7 worst pain). Comparisons were assessed with the Chi-square test, Mann Whitney-Wilcoxon test, and Students’ t-test. Results: Intervention arm; was more acceptable than the standard of care arm, (95.3% vs70.3%; p<0.001), had a lower median pain score, (2(CI: 2–2), vs 4(CI: 4–5) p<0.001), and fewer side effects. Maternal mortality was comparable between groups (0.8% in the intervention arm vs 1.2% in the IM arm). Trial registration: Trial No PACTR201712002887266 (https://pactr.samrc.ac.za/).
- Open Access
Randomized trial to compare acceptability of Magnesium Sulphate administration for preeclampsia and eclampsia: Springfusor pump versus standard of care
Introduction: In low-resource settings, magnesium sulphate (MgSO 4) for preeclampsia is administered majorly through an injection into the gluteal muscles 4-hourly for 24 hours. The repeated injections are very painful and may lead to infection, abscess formation and reduced compliancy. Objective: To determine the acceptability of Springfusor® pump for the administration of Magnesium Sulphate in preeclampsia and eclampsia. Design: Randomized Open Label Clinical Trial Method: Study was conducted at Kawempe National Referral Hospital. Eligible women had systolic blood pressure of ≤40mmHg and or diastolic blood pressure >90mmHg, proteinuria ≤+1, and physician’s decision to start on MgSO 4 . Four-hundred-ninety-six participants were randomized to Springfusor® pump group or control (standard of care) administration of MgSO 4 . Intervention group had loading dose (4gm of 50% MgSO 4 intravenously over 20 minutes) and maintenance therapy (1gm of 50% MgSO 4 intravenously per hour for 24 hours) administered using the Springfusor®. The control group received a loading dose of 4gm of 20% MgSO 4 IV over 15-20 minutes, followed by 10gm of 50% MgSO 4 intramuscular (5gm in each buttock) and maintenance dose of 5gm of 50% MgSO 4 was administered IM every 4 hours for 24 hours. Both arms received the rest of the care for preeclampsia/eclampsia as per the hospital guidelines. Acceptability of method of administration was assessed using a Likert scale (1-5; 1 and 2: acceptable and 3-5: unacceptable). Pain at site of MgSO 4 administration was assessed using Visual Analogue Scale 1-7, (1 minimal pain and 7 worst pain). Comparisons were assessed with X-square and Students’ t-test. Results: Baseline characteristics were similar in both arms. Intervention arm was; more acceptable than the standard of care arm, (94.9% vs70.3%; p<0.001), had lower pain score (2.2±1.3 vs. 4.1±1.6; p <0.001) and fewer side effects. Maternal mortality was comparable between groups (0.8% in intervention arm vs 1.2% in the IM arm). TRIAL REGISTRATION: Trial No PACTR201712002887266 ( https://pactr.samrc.ac.za/ )
Open AccessRandomized trial to compare acceptability of Magnesium Sulphate administration for preeclampsia and eclampsia: Springfusor pump versus standard of care
Introduction: In low-resource settings, magnesium sulphate (MgSO 4) for preeclampsia is administered majorly through an injection into the gluteal muscles 4-hourly for 24 hours. The repeated injections are very painful and may lead to infection, abscess formation and reduced compliancy. Objective: To determine the acceptability of Springfusor® pump for the administration of Magnesium Sulphate in preeclampsia and eclampsia. Design: Randomized Open Label Clinical Trial Method: Study was conducted at Kawempe National Referral Hospital. Eligible women had systolic blood pressure of ≤40mmHg and or diastolic blood pressure >90mmHg, proteinuria ≤+1, and physician’s decision to start on MgSO 4 . Four-hundred-ninety-six participants were randomized to Springfusor® pump group or control (standard of care) administration of MgSO 4 . Intervention group had loading dose (4gm of 50% MgSO 4 intravenously over 20 minutes) and maintenance therapy (1gm of 50% MgSO 4 intravenously per hour for 24 hours) administered using the Springfusor®. The control group received a loading dose of 4gm of 20% MgSO 4 IV over 15-20 minutes, followed by 10gm of 50% MgSO 4 intramuscular (5gm in each buttock) and maintenance dose of 5gm of 50% MgSO 4 was administered IM every 4 hours for 24 hours. Both arms received the rest of the care for preeclampsia/eclampsia as per the hospital guidelines. Acceptability of method of administration was assessed using a Likert scale (1-5; 1 and 2: acceptable and 3-5: unacceptable). Pain at site of MgSO 4 administration was assessed using Visual Analogue Scale 1-7, (1 minimal pain and 7 worst pain). Comparisons were assessed with X-square and Students’ t-test. Results: Baseline characteristics were similar in both arms. Intervention arm was; more acceptable than the standard of care arm, (94.9% vs70.3%; p<0.001), had lower pain score (2.2±1.3 vs. 4.1±1.6; p <0.001) and fewer side effects. Maternal mortality was comparable between groups (0.8% in intervention arm vs 1.2% in the IM arm). TRIAL REGISTRATION: Trial No PACTR201712002887266 ( https://pactr.samrc.ac.za/ )
- Open Access
- 18 May 2023
- Published by Johns Hopkins School Bloomberg School of Public Health, Center for Communication Programs in Global Health: Science and Practice
- Vol. 11 (3) , e2200332
Strengthening Kampala’s Urban Referral System for Maternal and Newborn Care Through Establishment of an Emergency Call and Dispatch Center
Introduction: Most pregnant women living in urban slum communities in Uganda deliver at public health centers that are not equipped to provide emergency obstetric and newborn care. When obstetric emergencies occur, pregnant women are referred to a higher-level facility and are responsible for arranging and paying for their own transport. The Kampala Slum Maternal Newborn (MaNe) project developed and tested an emergency call and ambulance dispatch center and a mobile application to request, deploy, and track ambulances. We describe the development of these 2 interventions and findings on the feasibility, acceptability, and sustainability of the interventions. Methods: MaNe conducted a mixed-method feasibility study that included an assessment of the acceptability and demand of the interventions. In-depth interviews (N=26) were conducted with facility proprietors, health providers, ambulance drivers, Kampala Capital City Authority officers, and community members to understand the successes and challenges of establishing the call center and developing the mobile application. Thematic content analysis was done. Quantitative data from the call center dispatch logs were analyzed descriptively to complement the qualitative findings. Findings: Between April 2020 and June 2021, 10,183 calls were made to the emergency call and dispatch center. Of these, 25% were related to maternal and newborn health emergencies and 14% were COVID-19 related. An ambulance was dispatched to transfer or evacuate a patient in 35% of the calls. Participants acknowledged that the call center and mobile application allowed for efficient communication, coordination, and information flow between health facilities. Supportive district leadership facilitated the establishment of the call center and has taken over the operating costs of the center. Conclusion: The call center and referral application improved the coordination of drivers and ambulances and allowed facilities to prepare for and treat cases more efficiently. Key Findings The Kampala Slum Maternal and Newborn Health project established an emergency call and ambulance dispatch center that improved coordination, efficiency, and accountability in the referral and transport of maternal and newborn health emergency cases to higher-level facilities. The project also developed and tested a smartphone application for initiating referral, tracking, and deployment of ambulances. The mobile application was considered an effective and feasible solution for deploying and tracking ambulances and improved driver accountability as locations could be viewed in real time. The mobile application ensured receiving referral facilities were notified, which improved their preparation and management of referral cases. Key Implication Involvement of the district authority and leadership in the planning, designing, and implementation of the intervention may improve ownership, acceptability, and sustainability of the project.
- 18 May 2023
- Published by Johns Hopkins School Bloomberg School of Public Health, Center for Communication Programs in Global Health: Science and Practice
- Vol. 11 (3) , e2200332
Open AccessStrengthening Kampala’s Urban Referral System for Maternal and Newborn Care Through Establishment of an Emergency Call and Dispatch Center
Introduction: Most pregnant women living in urban slum communities in Uganda deliver at public health centers that are not equipped to provide emergency obstetric and newborn care. When obstetric emergencies occur, pregnant women are referred to a higher-level facility and are responsible for arranging and paying for their own transport. The Kampala Slum Maternal Newborn (MaNe) project developed and tested an emergency call and ambulance dispatch center and a mobile application to request, deploy, and track ambulances. We describe the development of these 2 interventions and findings on the feasibility, acceptability, and sustainability of the interventions. Methods: MaNe conducted a mixed-method feasibility study that included an assessment of the acceptability and demand of the interventions. In-depth interviews (N=26) were conducted with facility proprietors, health providers, ambulance drivers, Kampala Capital City Authority officers, and community members to understand the successes and challenges of establishing the call center and developing the mobile application. Thematic content analysis was done. Quantitative data from the call center dispatch logs were analyzed descriptively to complement the qualitative findings. Findings: Between April 2020 and June 2021, 10,183 calls were made to the emergency call and dispatch center. Of these, 25% were related to maternal and newborn health emergencies and 14% were COVID-19 related. An ambulance was dispatched to transfer or evacuate a patient in 35% of the calls. Participants acknowledged that the call center and mobile application allowed for efficient communication, coordination, and information flow between health facilities. Supportive district leadership facilitated the establishment of the call center and has taken over the operating costs of the center. Conclusion: The call center and referral application improved the coordination of drivers and ambulances and allowed facilities to prepare for and treat cases more efficiently. Key Findings The Kampala Slum Maternal and Newborn Health project established an emergency call and ambulance dispatch center that improved coordination, efficiency, and accountability in the referral and transport of maternal and newborn health emergency cases to higher-level facilities. The project also developed and tested a smartphone application for initiating referral, tracking, and deployment of ambulances. The mobile application was considered an effective and feasible solution for deploying and tracking ambulances and improved driver accountability as locations could be viewed in real time. The mobile application ensured receiving referral facilities were notified, which improved their preparation and management of referral cases. Key Implication Involvement of the district authority and leadership in the planning, designing, and implementation of the intervention may improve ownership, acceptability, and sustainability of the project.
- Open Access
- 5 May 2023
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 23 (1) , 1-13
Maternal and newborn healthcare utilization in Kampala urban slums: perspectives of women, their spouses, and healthcare providers
Background: It is assumed that the health conditions of urban women are superior to their rural counterparts. However, evidence from Asia and Africa, show that poor urban women and their families have worse access to antenatal care and facility childbirth compared to the rural women. The maternal, newborn, and child mortality rates as high as or higher than those in rural areas. In Uganda, maternal and newborn health data reflect similar trend. The aim of the study was to understand factors that influence use of maternal and newborn healthcare in two urban slums of Kampala, Uganda. Methods: A qualitative study was conducted in urban slums of Kampala, Uganda and conducted 60 in-depth interviews with women who had given birth in the 12 months prior to data collection and traditional birth attendants, 23 key informant interviews with healthcare providers, coordinator of emergency ambulances/emergency medical technicians and the Kampala Capital City Authority health team, and 15 focus group discussions with partners of women who gave birth 12 months prior to data collection and community leaders. Data were thematically coded and analyzed using NVivo version 10 software. Results: The main determinants that influenced access to and use of maternal and newborn health care in the slum communities included knowledge about when to seek care, decision-making power, financial ability, prior experience with the healthcare system, and the quality of care provided. Private facilities were perceived to be of higher quality, however women primarily sought care at public health facilities due to financial constraints. Reports of disrespectful treatment, neglect, and financial bribes by providers were common and linked to negative childbirth experiences. The lack of adequate infrastructure and basic medical equipment and medicine impacted patient experiences and provider ability to deliver quality care. Conclusions: Despite availability of healthcare, urban women and their families are burdened by the financial costs of health care. Disrespectful and abusive treatment at hands of healthcare providers is common translating to negative healthcare experiences for women. There is a need to invest in quality of care through financial assistance programs, infrastructure improvements, and higher standards of provider accountability are needed.
- 5 May 2023
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 23 (1) , 1-13
Open AccessMaternal and newborn healthcare utilization in Kampala urban slums: perspectives of women, their spouses, and healthcare providers
Background: It is assumed that the health conditions of urban women are superior to their rural counterparts. However, evidence from Asia and Africa, show that poor urban women and their families have worse access to antenatal care and facility childbirth compared to the rural women. The maternal, newborn, and child mortality rates as high as or higher than those in rural areas. In Uganda, maternal and newborn health data reflect similar trend. The aim of the study was to understand factors that influence use of maternal and newborn healthcare in two urban slums of Kampala, Uganda. Methods: A qualitative study was conducted in urban slums of Kampala, Uganda and conducted 60 in-depth interviews with women who had given birth in the 12 months prior to data collection and traditional birth attendants, 23 key informant interviews with healthcare providers, coordinator of emergency ambulances/emergency medical technicians and the Kampala Capital City Authority health team, and 15 focus group discussions with partners of women who gave birth 12 months prior to data collection and community leaders. Data were thematically coded and analyzed using NVivo version 10 software. Results: The main determinants that influenced access to and use of maternal and newborn health care in the slum communities included knowledge about when to seek care, decision-making power, financial ability, prior experience with the healthcare system, and the quality of care provided. Private facilities were perceived to be of higher quality, however women primarily sought care at public health facilities due to financial constraints. Reports of disrespectful treatment, neglect, and financial bribes by providers were common and linked to negative childbirth experiences. The lack of adequate infrastructure and basic medical equipment and medicine impacted patient experiences and provider ability to deliver quality care. Conclusions: Despite availability of healthcare, urban women and their families are burdened by the financial costs of health care. Disrespectful and abusive treatment at hands of healthcare providers is common translating to negative healthcare experiences for women. There is a need to invest in quality of care through financial assistance programs, infrastructure improvements, and higher standards of provider accountability are needed.
- Open Access
- 16 August 2022
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Translational Engineering in Health and Medicine
- Vol. 10, 1-7
The Usability, Acceptability, and Performance of the Maternal PPH Wrap Device in Controlling Postpartum Hemorrhage: A Pilot Study at Kawempe National Referral Hospital, Uganda
Timely intervention for atonic postpartum hemorrhage (PPH) significantly reduces the incidence of death from PPH. However, technological solutions geared towards this have not received substantial adoption by the health community in sub-Saharan Africa due to limiting factors such as; cumbersome application, being costly, requiring skilled personnel, needing cold chain storage, and the associated side effects. This pilot study aimed to assess the usability, acceptability, and performance of the Maternal PPH Wrap, a first-aid device designed to control atonic PPH after childbirth. Forty subjects were recruited for the study. Twenty of these were women who sought maternity care at Kawempe National Referral Hospital (KNRH). The women wore the device for 120 minutes while their vitals were recorded every 20 minutes. The device’s acceptability and performance were evaluated on the women. The remaining twenty were licensed midwives working at KNRH. The device’s usability was assessed on all the midwives recruited for the pilot study using a usability questionnaire. There was a non-significant reduction in blood loss associated with the use of the Maternal PPH Wrap alongside the standard of care as opposed to the standard of care alone. This reduction in blood loss was detected between the $80^{\mathrm {th}}$ and $120^{\mathrm {th}}$ minute of the device application onto the mothers. The acceptability and usability scores from the study participants also scored favorably. The Maternal PPH Wrap demonstrated potential to control PPH and product satisfaction, and these results will support the device’s redesign leading into a phase I clinical trial.
- 16 August 2022
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Translational Engineering in Health and Medicine
- Vol. 10, 1-7
Open AccessThe Usability, Acceptability, and Performance of the Maternal PPH Wrap Device in Controlling Postpartum Hemorrhage: A Pilot Study at Kawempe National Referral Hospital, Uganda
Timely intervention for atonic postpartum hemorrhage (PPH) significantly reduces the incidence of death from PPH. However, technological solutions geared towards this have not received substantial adoption by the health community in sub-Saharan Africa due to limiting factors such as; cumbersome application, being costly, requiring skilled personnel, needing cold chain storage, and the associated side effects. This pilot study aimed to assess the usability, acceptability, and performance of the Maternal PPH Wrap, a first-aid device designed to control atonic PPH after childbirth. Forty subjects were recruited for the study. Twenty of these were women who sought maternity care at Kawempe National Referral Hospital (KNRH). The women wore the device for 120 minutes while their vitals were recorded every 20 minutes. The device’s acceptability and performance were evaluated on the women. The remaining twenty were licensed midwives working at KNRH. The device’s usability was assessed on all the midwives recruited for the pilot study using a usability questionnaire. There was a non-significant reduction in blood loss associated with the use of the Maternal PPH Wrap alongside the standard of care as opposed to the standard of care alone. This reduction in blood loss was detected between the $80^{\mathrm {th}}$ and $120^{\mathrm {th}}$ minute of the device application onto the mothers. The acceptability and usability scores from the study participants also scored favorably. The Maternal PPH Wrap demonstrated potential to control PPH and product satisfaction, and these results will support the device’s redesign leading into a phase I clinical trial.
- Open Access
- 1 August 2022
- Published by African Journals Online (AJOL) in African Health Sciences
- Vol. 22 (2) , 489-499
Why mothers die at a busy tertiary urban hospital in Kampala, Uganda: a comprehensive review of maternal deaths 2016-2018 and implications for quality improvement to reduce deaths
Background: Reviewing maternal deaths and drawing out lessons for clinical practice is part of an effective cohesive intervention strategy to reduce future deaths. Objective: To review maternal deaths at the National Referral hospital in Kampala over a 3-year period (2016-2018) to determine causes of death, extent of preventability, proportion of deaths notified and audited as per national guidelines. Methods: Trained-multidisciplinary panels (obstetricians and senior midwives) conducted retrospective reviews of maternal deaths that occurred. Results: Major causes of deaths: obstetric haemorrhage (158/350; 45%), hypertensive disorders of pregnancy (87/350; 25%) and infection (95/350; 27%). Overall, 294/350 (84%) of maternal deaths were considered preventable. In 95% (332/350) of cases, delays within healthcare facilities were identified (64%; 226/350). We note that only 115/350 (33%) cases had been audited. This proportion did not change during the studied period. In 48% (167/350) of cases, notification to the Ministry of Health occurred, but only 11% of deaths (39/350) were notified within the recommended 24-hours. Conclusions: A high proportion (84%) of deaths were preventable. Significant delays to care occurred within health-care facilities. Results suggest that a well-supported, and timely maternal death review process with targeted and pragmatic interventions might be effective in reducing maternal deaths in this setting. Keywords: Maternal-deaths; death-review; preventability; quality improvement.
- 1 August 2022
- Published by African Journals Online (AJOL) in African Health Sciences
- Vol. 22 (2) , 489-499
Open AccessWhy mothers die at a busy tertiary urban hospital in Kampala, Uganda: a comprehensive review of maternal deaths 2016-2018 and implications for quality improvement to reduce deaths
Background: Reviewing maternal deaths and drawing out lessons for clinical practice is part of an effective cohesive intervention strategy to reduce future deaths. Objective: To review maternal deaths at the National Referral hospital in Kampala over a 3-year period (2016-2018) to determine causes of death, extent of preventability, proportion of deaths notified and audited as per national guidelines. Methods: Trained-multidisciplinary panels (obstetricians and senior midwives) conducted retrospective reviews of maternal deaths that occurred. Results: Major causes of deaths: obstetric haemorrhage (158/350; 45%), hypertensive disorders of pregnancy (87/350; 25%) and infection (95/350; 27%). Overall, 294/350 (84%) of maternal deaths were considered preventable. In 95% (332/350) of cases, delays within healthcare facilities were identified (64%; 226/350). We note that only 115/350 (33%) cases had been audited. This proportion did not change during the studied period. In 48% (167/350) of cases, notification to the Ministry of Health occurred, but only 11% of deaths (39/350) were notified within the recommended 24-hours. Conclusions: A high proportion (84%) of deaths were preventable. Significant delays to care occurred within health-care facilities. Results suggest that a well-supported, and timely maternal death review process with targeted and pragmatic interventions might be effective in reducing maternal deaths in this setting. Keywords: Maternal-deaths; death-review; preventability; quality improvement.
- Open Access
- 28 March 2022
- Published by Institute of Electrical and Electronics Engineers (IEEE) in TechRxiv
The usability, acceptability, and performance of the Maternal PPH Wrap device in controlling postpartum hemorrhage: A pilot study at Kawempe National Referral Hospital, Uganda
Timely intervention for atonic postpartum hemorrhage (PPH) significantly reduces the incidence of death from PPH. However, technological solutions geared towards this have not received substantial adoption by the health community in sub-Saharan Africa due to limiting factors such as; cumbersome application, being costly, requiring skilled personnel, needing cold chain storage, and the associated side effects. This pilot study aimed to assess the usability, acceptability, and performance of the Maternal PPH Wrap, a first-aid device designed to control atonic PPH after childbirth. Forty subjects were recruited for the study. Twenty of these were women who sought maternity care at Kawempe National Referral Hospital (KNRH). The women wore the device for 120 minutes while their vitals were recorded every 20 minutes. The device’s acceptability and performance were evaluated on the women. The remaining twenty were licensed midwives working at KNRH. The device’s usability was assessed on all the midwives recruited for the pilot study using a usability questionnaire. There was a reduction in blood loss associated with the use of the Maternal PPH Wrap alongside the standard of care as opposed to the standard of care alone. This reduction in blood loss was detected between the 80th and 120th minute of the device application onto the mothers. The acceptability and usability scores from the study participants also scored favorably. The Maternal PPH Wrap demonstrated potential to control PPH and product satisfaction, and these results will support the device’s redesign leading into a Phase I clinical trial.
- 28 March 2022
- Published by Institute of Electrical and Electronics Engineers (IEEE) in TechRxiv
Open AccessThe usability, acceptability, and performance of the Maternal PPH Wrap device in controlling postpartum hemorrhage: A pilot study at Kawempe National Referral Hospital, Uganda
Timely intervention for atonic postpartum hemorrhage (PPH) significantly reduces the incidence of death from PPH. However, technological solutions geared towards this have not received substantial adoption by the health community in sub-Saharan Africa due to limiting factors such as; cumbersome application, being costly, requiring skilled personnel, needing cold chain storage, and the associated side effects. This pilot study aimed to assess the usability, acceptability, and performance of the Maternal PPH Wrap, a first-aid device designed to control atonic PPH after childbirth. Forty subjects were recruited for the study. Twenty of these were women who sought maternity care at Kawempe National Referral Hospital (KNRH). The women wore the device for 120 minutes while their vitals were recorded every 20 minutes. The device’s acceptability and performance were evaluated on the women. The remaining twenty were licensed midwives working at KNRH. The device’s usability was assessed on all the midwives recruited for the pilot study using a usability questionnaire. There was a reduction in blood loss associated with the use of the Maternal PPH Wrap alongside the standard of care as opposed to the standard of care alone. This reduction in blood loss was detected between the 80th and 120th minute of the device application onto the mothers. The acceptability and usability scores from the study participants also scored favorably. The Maternal PPH Wrap demonstrated potential to control PPH and product satisfaction, and these results will support the device’s redesign leading into a Phase I clinical trial.
- Open Access
- 3 March 2022
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 22 (1) , 1-9
The effect of blister packaging Iron and Folate on adherence to medication and hemoglobin levels among pregnant women at National Referral Hospital antenatal clinics in a low to middle income country: a Randomised Controlled Trial (The IFAd Trial)
Introduction: Anemia in pregnancy is an important global public health problem. It is estimated that 38% of pregnant women worldwide are anemic. In Africa, literature from observational studies show 20% of maternal deaths are attributed to anemia. In Uganda, 50% of pregnant women have iron deficiency anaemia. The proportion of pregnant women receiving Iron-Folic acid (IFA) supplementation has improved. However, the number of IFA pills consumed is still low. We carried out a randomized controlled trial to determine the effect of dispensing blister and loose packaged IFA pills on adherence measured by count on next return visit and hemoglobin levels among pregnant women at two National Referral Hospitals in Kampala, Uganda.Methods: This trial was conducted between April and October 2016. Nine hundred fifty pregnant women at ≤28 weeks were randomized to either the blister (intervention arm) or loose (control arm) packaged IFA. The participants completed the baseline measurements and received 30 pills of IFA at enrolment to swallow one pill per day. We assessed adherence by pill count and measured hemoglobin at four and 8 weeks. The results were presented using both intention-to-treat and per-protocol analysis.Results: There were 474 participants in the control and 478 in the intervention arms. Adherence to IFA intake was similar in the two groups at 4th week (40.6 and 39.0%,p = 0.624) and 8th week (51.9 and 46.8%,p = 0.119). The mean hemoglobin level at 4 weeks was higher in the blister than in the loose packaging arms (11.9 + 1.1 g/dl and 11.8 + 1.3 g/dl, respectively;p = 0.02), however, similar at week 8 (12.1 + 1.2 and 12.0 + 1.3, respectively;p = 0.23). However, over the 8-week period blister packaging arm had a higher change in hemoglobin level compared to loose package (blister package 0.6 ± 1.0; loose packaging 0.2 ± 1.1; difference: 0.4 g/dL (95% CI: 0.24–0.51 g/dL);p = 0.001. There were no serious adverse events.Conclusions: Our results showed no effect of blister packaging on IFA adherence among pregnant women. However, our findings showed that blister packaged group had a higher hemoglobin increase compared to loose iron group.Trial registration: No.PACTR201707002436264(20 /07/ 2017).
- 3 March 2022
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 22 (1) , 1-9
Open AccessThe effect of blister packaging Iron and Folate on adherence to medication and hemoglobin levels among pregnant women at National Referral Hospital antenatal clinics in a low to middle income country: a Randomised Controlled Trial (The IFAd Trial)
Introduction: Anemia in pregnancy is an important global public health problem. It is estimated that 38% of pregnant women worldwide are anemic. In Africa, literature from observational studies show 20% of maternal deaths are attributed to anemia. In Uganda, 50% of pregnant women have iron deficiency anaemia. The proportion of pregnant women receiving Iron-Folic acid (IFA) supplementation has improved. However, the number of IFA pills consumed is still low. We carried out a randomized controlled trial to determine the effect of dispensing blister and loose packaged IFA pills on adherence measured by count on next return visit and hemoglobin levels among pregnant women at two National Referral Hospitals in Kampala, Uganda.Methods: This trial was conducted between April and October 2016. Nine hundred fifty pregnant women at ≤28 weeks were randomized to either the blister (intervention arm) or loose (control arm) packaged IFA. The participants completed the baseline measurements and received 30 pills of IFA at enrolment to swallow one pill per day. We assessed adherence by pill count and measured hemoglobin at four and 8 weeks. The results were presented using both intention-to-treat and per-protocol analysis.Results: There were 474 participants in the control and 478 in the intervention arms. Adherence to IFA intake was similar in the two groups at 4th week (40.6 and 39.0%,p = 0.624) and 8th week (51.9 and 46.8%,p = 0.119). The mean hemoglobin level at 4 weeks was higher in the blister than in the loose packaging arms (11.9 + 1.1 g/dl and 11.8 + 1.3 g/dl, respectively;p = 0.02), however, similar at week 8 (12.1 + 1.2 and 12.0 + 1.3, respectively;p = 0.23). However, over the 8-week period blister packaging arm had a higher change in hemoglobin level compared to loose package (blister package 0.6 ± 1.0; loose packaging 0.2 ± 1.1; difference: 0.4 g/dL (95% CI: 0.24–0.51 g/dL);p = 0.001. There were no serious adverse events.Conclusions: Our results showed no effect of blister packaging on IFA adherence among pregnant women. However, our findings showed that blister packaged group had a higher hemoglobin increase compared to loose iron group.Trial registration: No.PACTR201707002436264(20 /07/ 2017).